Clinical Trial Update: Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a venetoclax-based, anthracycline-free regimen for newly diagnosed CBFB-MYH11-positive acute myeloid leukemia is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venclexta (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING